Resultados de la búsqueda 121-130 of 12774 for Antifungal Resistance

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... resistant). Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study Of ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    An atlas with these properties could improve DBS lead targeting. Treatment Resistant Depression Subcallosal Cingulate Network. Rochester, Minn. The purpose of ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study Of ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study To ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study To Detect Pancreatic Cancer Using Circulating Tumor ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... resistant). Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study To Detect Pancreatic Cancer Using Circulating Tumor ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... resistant). Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an ...